[Form 4] Oblong, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jonathan Schechter, a director of Oblong, Inc. (OBLG), reported purchasing 5,000 shares of common stock on 09/17/2025 at a price of $2.6951 per share, leaving him with 15,000 shares beneficially owned. The Form 4 also discloses outstanding Common Warrants with an exercise price of $3.4144, originally exercisable on 10/01/2023 and expiring on 10/01/2028, which relate to 61,351 underlying common shares beneficially owned directly.

The filing is a routine insider reporting of a purchase and the existence of warrants; it documents the current direct holdings and the terms of the warrants without additional commentary or explanation.

Positive

• Director purchased additional common stock (5,000 shares), increasing direct ownership to 15,000 shares
• Clear disclosure of warrants with exercise price, exercisable date, expiration, and underlying share count (61,351), providing transparency

Negative

• Warrants outstanding for 61,351 underlying shares could lead to future dilution if exercised
• Form provides no explanation for the purchase or context on whether purchases will continue

Insights

Financial Analyst

TL;DR: Insider bought 5,000 OBLG shares at $2.6951; holdings now 15,000 shares and 61,351 shares underlying warrants.

The reported purchase increases the director's direct equity stake to 15,000 shares, showing a modest additional ownership position at a per-share price of $2.6951. The Form 4 confirms outstanding warrants exercisable at $3.4144 that cover 61,351 underlying shares and expire 10/01/2028, which are recorded as directly beneficially owned. For valuation context, the purchase price is below the listed warrant exercise price, but the filing contains no company-level financials or transaction rationale.

Corporate Governance Expert

TL;DR: Director reported a routine open-market purchase and disclosed direct beneficial ownership including warrants.

The filing follows Section 16 reporting requirements: an acquisition on 09/17/2025 and clear disclosure of derivative instruments. It states the warrants' initial exercise timing and five-year post-exercise expiry structure. There are no indicated related-party transfers, amendments, or departures from standard disclosure practice in this Form 4. The disclosure is complete for the transactions shown but provides no details on source of funds or any agreements tied to the issuance of the warrants.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SCHECHTER JONATHAN

(Last) (First) (Middle)

110 16TH STREET

SUITE 1400 #1024

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oblong, Inc. [ OBLG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	09/17/2025		P		5,000	A	$2.6951	15,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Warrant(1)	$3.4144							10/01/2023	10/01/2028	Common Stock	61,351		61,351	D

Explanation of Responses:

1. Represents the issuance of warrants to purchase common stock of the issuer. The initial exercise date of the warrants was six months from the grant date, and the warrants expire on the fifth anniversary of the initial exercise date.

	/s/ Jonathan Schechter	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jonathan Schechter report on Form 4 for OBLG?

He reported acquiring 5,000 shares of Oblong common stock on 09/17/2025 at $2.6951, leaving him with 15,000 shares beneficially owned.

What warrants are disclosed in the filing for OBLG?

The filing discloses Common Warrants with an exercise price of $3.4144, initial exercise date 10/01/2023, expiration 10/01/2028, and 61,351 underlying common shares.

Does the Form 4 show direct or indirect ownership?

The filing lists the ownership as Direct (D) for both the reported common stock and the warrants' underlying shares.

When do the disclosed warrants expire?

The warrants are shown as expiring on 10/01/2028.

How much did the director pay per share in the reported purchase?

The reported purchase price was $2.6951 per share for the 5,000 shares acquired on 09/17/2025.